Building valued partnerships with the medical professionals who prescribe and recommend our products is both Takeda’s greatest challenge and our greatest reward. These aspirations as well as our commitment to provide medicines that offer real promise to patients, drives us to seek innovative and efficient ways of presenting our products to the Australian market.
For our medicines to be considered as the first option within their therapeutic area, Takeda understands that we must first earn this place in the minds of those who prescribe and recommend our medicines.
Through our commitment to the ethical and professional delivery of quality medical education, Takeda is continually building valued relationships with the medical community. This is achieved by the creation of focused disease state education programs, and the facilitation of knowledge sharing between thought leaders and primary care practitioners. While we always strive to keep Somac® (pantoprazole) and Alvesco ® (ciclesonide) at the "top of the mind" of Australian prescribers, our activities are often unrelated to our products and instead focus on topics of clearly identified educational needs within the areas of Gastroenterology and Respiratory Medicine.
In addition to building relationships with individual healthcare professionals, Takeda seeks to develop productive partnerships with the peak bodies that share our therapeutic focus. For example, The Gastroenterology Society of Australia guides us in the field of gastroenterology. In the area of respiratory medicine, our organisation has developed positive relationships with both the National Asthma Council and the Australian Lung Foundation. Nycomed is also excited by the prospect of pioneering new relationships with peak bodies in our emerging areas of therapeutic interest.
As a member of Medicines Australia, Takeda is devoted to strengthening the pharmaceutical industry’s position as a partner in quality healthcare delivery. This is achieved through the ethical promotion of our products and our support of the Medicines Australia code of conduct. Takeda and its people are proud of their contribution to the Australian healthcare environment and seek to ensure that our organisation acts as a trusted pharmaceutical partner.
Our commitment to providing quality medicines also encompasses our focus on delivering treatments that are considered cost effective by government and private funders. By offering value for money we ensure that our products are widely available to the Australian community.
Every day across Australia, our highly trained industry-accredited representatives bring life to our products and services. They are the face of Takeda. Our professional team is committed to our vision to become the preferred pharmaceutical company by being responsive, reliable and by understanding customer needs. We look forward to building a trusted partnership with you and positively contributing to the health of Australians.